Phase 3 manufacturing campaign on track for completion no later than third quarter 2026, supporting expected pivotal trial in advanced ...
Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results